Resomelagon

Resomelagon

SCHEMBL23716726

N=C(N)NN=CC=Cc1cccn1-c1ccccc1[N+](=O)[O-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.43
▸ MAPT P10636 8/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ GAA P10253 3/20 0.43
▸ KMT2A Q03164 5/20 0.42
▸ RAB9A P51151 6/20 0.42
▸ NPC1 O15118 5/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ PKM P14618 1/20 0.41
▸ LMNA P02545 4/20 0.40
▸ HTT P42858 1/20 0.40
▸ POLB P06746 1/20 0.39
▸ ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resomelagon SCHEMBL12123680 1.00 ALDH1A1 (0.43) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30084728 1.00 ALDH1A1 (0.43) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30064309 0.98 ALDH1A1 (0.42) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30862151 0.96 RAB9A (0.44) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30853066 0.95 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL28929658 0.95 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL22658047 0.95 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30084718 0.93 NPC1 (0.44) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30084719 0.93 MAPT (0.41) ALDH1A1MAPTSMN1; SMN2GAAKMT2A
Resomelagon SCHEMBL30065231 0.92 ALDH1A1 (0.45) ALDH1A1MAPTSMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743064-B1 TREATMENT OF PROTEINURIA SYNACT PHARMA APS (DK) 2021-08-11 — — EP claimed
CN-120584099-A Polymorphs of a phenylpyrrole hydrazine formamidine compound 西奈克制药有限公司 2025-09-02 — — CN disclosed
Send feedback